Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis

NCT06146972 is registered in ClinicalTrials.gov with Yanfeng Hou as lead sponsor.

NCT NCT06146972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06146972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis
Lead sponsor
Yanfeng Hou
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2021
Completion date
May 31, 2024
Enrollment
117 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis, therapy